Filter programs:

37 Programs

  • Interview and Lecture

    Exploring the Potential Role of PROTAC Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer

    Explore program
    • October 2025 1.25 ABIM MOC, ABS MOC 58min
      • E
      Erika Hamilton
    • October 2025 0.75 ABIM MOC, ABS MOC 29min
      • E
      Erika Hamilton
  • Webinar Proceedings

    Current and Future Integration of Antibody-Drug Conjugates into the Management of Metastatic Breast Cancer

    Explore program
  • 5-Minute Journal Club

    Defining the Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Breast Cancer — Issue 4

    Explore program
  • Webinar Proceedings

    The Implications of Recent Datasets for the Current and Future Management of Breast Cancer — An ASCO 2025 Review

    Explore program